March 5, 2025

LISTEN: A JAMA Network Learning podcast interview with Dr. Anand Jillella, author of the newly published results of study EA9131 in JAMA Oncology

January 5, 2025

NCI’s myeloMATCH precision medicine initiative pushes the envelop in myeloid leukemia care

November 25, 2024

Press Release: ECOG-ACRIN adds a late-breaking abstract to its ASH 2024 presentation line-up

October 30, 2024

WATCH: Behind the ECOG-ACRIN E1910 trial with lead investigator Dr. Mark Litzow

August 21, 2024

How a patient’s role in a clinical trial for acute lymphocytic leukemia brought a cancer-free diagnosis, FDA approval

August 20, 2024

Blinatumomab improves 3-year overall survival in B-ALL versus chemotherapy (study E1910)

July 24, 2024

Press Release: New England Journal of Medicine publishes practice-changing E1910 trial results

July 2, 2024

The Summer 2024 advocacy blog, Considering Clinical Trials, is now available

June 14, 2024

E1910 trial leads to an FDA approval in B-cell acute lymphoblastic leukemia (B-ALL)

ECOG-ACRIN Cancer Research Group